Catalent to Create a European Center of Excellence Center in Limoges

20th July 2020

Catalent to Create a European Center of Excellence Center in Limoges

US-based CDMO Catalent plans to invest $30 million (€27 million) at its facility in Limoges, France, to create a European center of excellence for clinical biologics formulation development and drug product fill-finish services. The Limoges site, which employs over 170 staff, will be fully modernized to handle large molecule programs, with additional capacity for small molecule dosage form development.

The facility will work closely with Catalent’s other biologics sites in Anagni, Italy, Brussels, Belgium, and the US-sites in Bloomington, Indiana and Madison, Wisconsin, to provide integrated clinical development and commercial manufacturing solutions.
The modernization of the 17.000 m2 facility will include the installation of an Optima high-speed flexible line capable of filling vials, syringes or cartridges under barrier isolator technology, as well as enhancements to its analytical and quality control laboratories, which are scheduled to begin in September 2020, with completion anticipated in 2022. Catalent also plans to gradually hire around 80 additional employees.

The project is being supported by the Prefecture of Haute-Vienne, the Metropolitan Area of Limoges, the Limoges Haute-Vienne Chamber of Commerce and Industry and the Regional Council of Nouvelle Aquitaine with a grant of €1.3 million.
Mario Gargiulo, Region President, Catalent Biologics Europe said: “The European pharmaceutical market is thriving, and France is currently one of the top five producers in Europe. Our new center of excellence in Limoges will strengthen Catalent Biologics’ global and European capacities and our ability to bring new biologic treatments to market, faster.”
Alain Rousset, President of Region Nouvelle-Aquitaine, added, "From the outset, we supported this project to diversify Catalent's activities in Limoges. This project contributes to the development of our industrial capacities in the health sector."

For more information visit

View more Industry News

Latest News